Is a complete BCBA/BIOXD research report available?

No complete published report is available for bcba/BIOXD (BCBA/BIOXD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BIOXD (BCBA/BIOXD)

Buenos Aires Stock Exchange: BCBA/BIOXD · USD

$0.24

-0.01 (-5.5%)· Recorded snapshot

Market cap	22.4B
Revenue (ttm)	352.3B
Net income (ttm)	-69.5B
EPS (ttm)	-$1,133
Volume	648

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 352.3B
Net income (ttm): -69.5B
EPS (ttm): -$1,133
Market cap: 22.4B

Metric	Value
Amount currency	ARS
Country	Cayman Islands
Country code	AR
Earnings date	2026-11-13
Employees	751
Employees change	362
Employees growth	93.06%
Enterprise value	$406.6B
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2001
Industry	Agricultural Inputs
Is primary listing	No
ISIN number	ARBCOM4603K3
Last earnings date	2026-09-15
Last refreshed	2026-10-30
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	$22.4B
Next earnings date	2026-11-13
Price	$0.24
Price currency	USD
Sector	Materials
SIC code	2870
Stock price date	2026-10-29
Symbol	bcba/BIOXD
Website	https://investors.biocerescrops.com/home/default.aspx

Metric

Value

Amount currency

ARS

Country

Cayman Islands

Country code

Earnings date

2026-11-13

Employees

751

Employees change

362

Employees growth

93.06%

Enterprise value

$406.6B

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

June

Founded

2001

Industry

Agricultural Inputs

Is primary listing

ISIN number

ARBCOM4603K3

Last earnings date

2026-09-15

Last refreshed

2026-10-30

Last stock split date

2024-01-24

Last stock split type

Forward

Market cap

$22.4B

Next earnings date

2026-11-13

Price

$0.24

Price currency

USD

Sector

Materials

SIC code

2870

Stock price date

2026-10-29

Symbol

bcba/BIOXD

Website

https://investors.biocerescrops.com/home/default.aspx

Metric	Value
Earnings yield	-305.98%
EV/EBITDA	16.34x
EV/FCF	3.33x
EV/Sales	1.11x
FCF / EV yield	30.02%
FCF yield	544.43%
P/(FCF - SBC) ratio	0.19x
P/(OCF - SBC) ratio	0.18x
P/B ratio	0.24x
P/FCF ratio	0.18x
P/OCF ratio	0.18x
P/S ratio	0.06x
Price/EBITDA ratio	0.95x
Sector P/E	13.6x

Metric

Value

Earnings yield

-305.98%

EV/EBITDA

16.34x

EV/FCF

3.33x

EV/Sales

1.11x

FCF / EV yield

30.02%

FCF yield

544.43%

P/(FCF - SBC) ratio

0.19x

P/(OCF - SBC) ratio

0.18x

P/B ratio

0.24x

P/FCF ratio

0.18x

P/OCF ratio

0.18x

P/S ratio

0.06x

Price/EBITDA ratio

0.95x

Sector P/E

13.6x

Metric	Value
EBIT margin	-0.21%
EBITDA margin	6.72%
FCF margin	28.74%
Gross margin	34.69%
Operating margin	-0.21%
Pretax margin	-19.76%
Profit margin	-19.72%
ROA	-0.05%
ROA (5Y)	2.51%
ROCE	-0.24%
ROE	-28.05%
ROE (5Y)	-7.8%
ROIC	-0.16%
ROIC (5Y)	2.38%
SBC / revenue	0.74%
Tax / revenue	1.43%

Metric

Value

EBIT margin

-0.21%

EBITDA margin

6.72%

FCF margin

28.74%

Gross margin

34.69%

Operating margin

-0.21%

Pretax margin

-19.76%

Profit margin

-19.72%

ROA

-0.05%

ROA (5Y)

2.51%

ROCE

-0.24%

ROE

-28.05%

ROE (5Y)

-7.8%

ROIC

-0.16%

ROIC (5Y)

2.38%

SBC / revenue

0.74%

Tax / revenue

1.43%

Metric	Value
EPS growth years	0
FCF growth 3Y	140.54%
Gross profit growth	-44.94%
Gross profit growth (Q)	-45.76%
Gross profit growth 3Y	-22.3%
Gross profit growth 5Y	0.5%
Net income growth quarters	1
Net income growth years	0
OCF growth	1,344.86%
OCF growth 3Y	93.85%
Revenue growth	-37.96%
Revenue growth (Q)	-23.35%
Revenue growth (QoQ)	49.21%
Revenue growth 3Y	-17%
Revenue growth 5Y	6.47%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth years

FCF growth 3Y

140.54%

Gross profit growth

-44.94%

Gross profit growth (Q)

-45.76%

Gross profit growth 3Y

-22.3%

Gross profit growth 5Y

0.5%

Net income growth quarters

Net income growth years

OCF growth

1,344.86%

OCF growth 3Y

93.85%

Revenue growth

-37.96%

Revenue growth (Q)

-23.35%

Revenue growth (QoQ)

49.21%

Revenue growth 3Y

-17%

Revenue growth 5Y

6.47%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-3.6B
Depreciation and amortization	$25.3B
EBIT	$-740.8M
EBITDA	$23.7B
EPS	$-1,132.56
Financing cash flow	$-130.7B
Free cash flow	$122.1B
Free cash flow minus SBC	$119B
Gross profit	$122.2B
Income taxes	$5B
Investing cash flow	$-7.8B
Net borrowing	$-105.6B
Net cash flow	$-27.8B
Net income	$-69.5B
Operating cash flow minus SBC	$122.6B
Operating income	$-740.8M
Revenue	$352.3B
Stock-based compensation	$3.1B

Metric

Value

Capital expenditures

$-3.6B

Depreciation and amortization

$25.3B

EBIT

$-740.8M

EBITDA

$23.7B

EPS

$-1,132.56

Financing cash flow

$-130.7B

Free cash flow

$122.1B

Free cash flow minus SBC

$119B

Gross profit

$122.2B

Income taxes

$5B

Investing cash flow

$-7.8B

Net borrowing

$-105.6B

Net cash flow

$-27.8B

Net income

$-69.5B

Operating cash flow minus SBC

$122.6B

Operating income

$-740.8M

Revenue

$352.3B

Stock-based compensation

$3.1B

Metric	Value
Book value per share	$910.80
Debt / EBITDA	14.83
Debt / equity	3.69
Debt / FCF	2.87
Goodwill	$55.4B
Interest coverage	-0.01
Long-term assets	$367.7B
Long-term liabilities	$193.2B
Net cash (debt)	$-332.7B
Net cash / market cap	-1,483.61%
Net debt / EBITDA	14.07
Net debt / equity	3.5
Net debt / FCF	2.73
Piotroski F-Score	3
Property, plant and equipment	$110.1B
Shareholders' equity	$95B
Tangible book value	$-117.3B
Tangible book value per share	$-1,844.89
Total assets	$698.2B
Total cash	$18.1B
Total debt	$350.8B
Total liabilities	$603.3B

Metric

Value

Book value per share

$910.80

Debt / EBITDA

14.83

Debt / equity

3.69

Debt / FCF

2.87

Goodwill

$55.4B

Interest coverage

-0.01

Long-term assets

$367.7B

Long-term liabilities

$193.2B

Net cash (debt)

$-332.7B

Net cash / market cap

-1,483.61%

Net debt / EBITDA

14.07

Net debt / equity

3.5

Net debt / FCF

2.73

Piotroski F-Score

Property, plant and equipment

$110.1B

Shareholders' equity

$95B

Tangible book value

$-117.3B

Tangible book value per share

$-1,844.89

Total assets

$698.2B

Total cash

$18.1B

Total debt

$350.8B

Total liabilities

$603.3B

Metric	Value
Asset turnover	0.39
Current assets	$330.5B
Current liabilities	$410.1B
Current ratio	0.81
Inventory turnover	2.27
Net working capital	$154.1B
Quick ratio	0.46
Working capital	$-76.7B
Working capital turnover	-8,648.12

Metric

Value

Asset turnover

0.39

Current assets

$330.5B

Current liabilities

$410.1B

Current ratio

0.81

Inventory turnover

2.27

Net working capital

$154.1B

Quick ratio

0.46

Working capital

$-76.7B

Working capital turnover

-8,648.12

Metric	Value
Buyback yield / dilution	-1.27%
Shareholder yield	-1.27%

Metric

Value

Buyback yield / dilution

-1.27%

Shareholder yield

-1.27%

Metric	Value
150-day SMA	$0.42
1D price change	-5.49%
1M price change	-36.58%
1M total return	-36.58%
1W price change	-11.72%
1W total return	-11.72%
1Y price change	-87.98%
1Y return CAGR	-88%
1Y total return	-87.98%
20-day SMA	$0.31
200-day SMA	$0.52
3M price change	-30.55%
3M total return	-30.55%
3Y price change	-97.76%
3Y return CAGR	-71.79%
3Y total return	-97.76%
50-day SMA	$0.38
50-day SMA vs 200-day SMA	50under200
52-week high	$2.14
52-week high date	2025-11-03
52-week low	$0.24
52-week low date	2026-10-27
5Y price change	-98.25%
5Y return CAGR	-55.48%
5Y total return	-98.25%
6M price change	-54.53%
6M total return	-54.53%
All-time high	$16.80
All-time high date	2021-11-24
All-time low	$0.24
All-time low date	2026-10-27
Average true range (ATR)	$0.03
Average volume	7.1K
Change from 52-week high	-88.74%
Change from 52-week low	2.12%
Change from all-time high	-98.57%
Change from all-time low	2.12%
Change from open	-6.59%
Day's gap	1.18%
Dollar volume	$156
High price	$0.26
Low price	$0.24
Monthly RSI	27.1
Open price	$0.26
Position in 52-week range	19.05%
Previous close	$0.26
Price vs 150-day SMA	-43.2%
Price vs 20-day SMA	-22.31%
Price vs 200-day SMA	-53.7%
Price vs 50-day SMA	-36.11%
Relative volume	0.09
RSI	24.02
Sharpe ratio	-1.96
Sharpe ratio (3Y)	-1.38
Sortino ratio	-2.6
Sortino ratio (3Y)	-1.9
Volume	648
Weekly RSI	25.77
YTD price change	-82.34%
YTD total return	-82.34%

Metric

Value

150-day SMA

$0.42

1D price change

-5.49%

1M price change

-36.58%

1M total return

-36.58%

1W price change

-11.72%

1W total return

-11.72%

1Y price change

-87.98%

1Y return CAGR

-88%

1Y total return

-87.98%

20-day SMA

$0.31

200-day SMA

$0.52

3M price change

-30.55%

3M total return

-30.55%

3Y price change

-97.76%

3Y return CAGR

-71.79%

3Y total return

-97.76%

50-day SMA

$0.38

50-day SMA vs 200-day SMA

50under200

52-week high

$2.14

52-week high date

2025-11-03

52-week low

$0.24

52-week low date

2026-10-27

5Y price change

-98.25%

5Y return CAGR

-55.48%

5Y total return

-98.25%

6M price change

-54.53%

6M total return

-54.53%

All-time high

$16.80

All-time high date

2021-11-24

All-time low

$0.24

All-time low date

2026-10-27

Average true range (ATR)

$0.03

Average volume

7.1K

Change from 52-week high

-88.74%

Change from 52-week low

2.12%

Change from all-time high

-98.57%

Change from all-time low

2.12%

Change from open

-6.59%

Day's gap

1.18%

Dollar volume

$156

High price

$0.26

Low price

$0.24

Monthly RSI

27.1

Open price

$0.26

Position in 52-week range

19.05%

Previous close

$0.26

Price vs 150-day SMA

-43.2%

Price vs 20-day SMA

-22.31%

Price vs 200-day SMA

-53.7%

Price vs 50-day SMA

-36.11%

Relative volume

0.09

RSI

24.02

Sharpe ratio

-1.96

Sharpe ratio (3Y)

-1.38

Sortino ratio

-2.6

Sortino ratio (3Y)

-1.9

Volume

648

Weekly RSI

25.77

YTD price change

-82.34%

YTD total return

-82.34%

Metric	Value
Float	44.9M
Shares change (QoQ)	0%
Shares change (YoY)	1.27%
Shares held by insiders	1.31%
Shares held by institutions	6.3%
Short ratio	2.8 days

Metric

Value

Float

44.9M

Shares change (QoQ)

Shares change (YoY)

1.27%

Shares held by insiders

1.31%

Shares held by institutions

6.3%

Short ratio

2.8 days

BCBA/BIOXD (BCBA/BIOXD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BIOXD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BIOXD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BIOXD

Frequently asked questions